Columbia University researchers have discovered a new way to create quantum materials. By utilising the chemistry of atomic orbitals, they've found a novel source of "frustration" that leads to complex quantum behaviours
Teva and Cephalon faced the €60.5 million antitrust fine, after both companies were found to be actively suppressing the existence of cheaper medicine.
The Oxford and AstraZeneca vaccine trial gave an accidental half-dose to 3,000 people - but this mistake is the reason the vaccine acted as 90% efficient.
Dr Ganesan Baranidharan, consultant in anaesthesia and pain medicine at the Leeds Teaching Hospitals NHS Trust, explains the power of neuromodulation for managing chronic pain and explains why comprehensive evidence is needed.
The Harvard-Smithsonian Center for Astrophysics found that growing interest in moon resources could create international tension, as extraction becomes possible.
COVID-19 came from Wuhan, China, but the conditions that enabled the virus to jump from animal to human are not unique - so where could the next pandemic begin?
Prime Minister Boris Johnson yesterday (23 November) announced his UK winter plan to the House of Commons, proposing a mass community testing scheme, stricter Tiers, and weekly tests for prison staff.
Scientists looked at calculations of how dry the air could become throughout the 21st century - it seems that wildfires in California and Nevada are predicted to increase in ferocity.
Today (20 November) Pfizer and BioNTech are sending their drug for approval to the FDA, meaning that the most vulnerable Americans could get the vaccine in December.
Asymptomatic older patients of COVID-19 are one of the most difficult to identify - now, researchers find that delirium could be an indicator of the virus
New research explores the link between ethnicity and ESKD, which finds that Afro-Caribbean patients are four times more likely to undergo COVID hospitalisation.
While US researchers are rightfully examining ethnicity and gender in their fields, the data for LGBTQ people in STEM fields has been notoriously lacking, until now
New data from the Oxford COVID vaccine trial shows that the UK antidote is working well at Phase two, with defining percentages expected after Phase Three is complete.
EU Commissioner Mariya Gabriel shares her ambitious policy plans on the coronavirus pandemic, especially in relation to research and innovation in Europe.
